Bradsaúde S.A. (BVMF:SAUD3)
15.50
+0.90 (6.16%)
Sep 10, 2026, 5:05 PM GMT-3
Bradsaúde Revenue
Bradsaúde had revenue of 8.76B BRL in the quarter ending June 30, 2026, with 1,262.84% growth. This brings the company's revenue in the last twelve months to 10.68B, up 328.07% year-over-year. In the year 2025, Bradsaúde had annual revenue of 2.55B with 5.41% growth.
Revenue (ttm)
10.68B
Revenue Growth
+328.07%
P/S Ratio
3.99
Revenue / Employee
5.46M
Employees
1,957
Market Cap
42.68B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.55B | 130.53M | 5.41% |
| Dec 31, 2024 | 2.41B | 153.22M | 6.78% |
| Dec 31, 2023 | 2.26B | 303.39M | 15.49% |
| Dec 31, 2022 | 1.96B | -35.74M | -1.79% |
| Dec 31, 2021 | 1.99B | 111.24M | 5.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Rede D'Or São Luiz | 57.79B |
| Raia Drogasil | 46.53B |
| Empreendimentos Pague Menos | 15.64B |
| Diagnósticos da América | 9.32B |
| Hypera | 8.82B |
| Fleury | 8.79B |
| Dimed S.A. Distribuidora de Medicamentos | 5.90B |
| Oncoclínicas do Brasil Serviços Médicos | 4.99B |
Bradsaúde News
- 5 weeks ago - Bradsaúde Earnings Call Transcript: Q2 2026 - Transcripts
- 5 weeks ago - Bradsaúde Earnings release: Q2 2026 - Filings
- 5 weeks ago - Bradsaúde Slides: Q2 2026 - Filings
- 5 weeks ago - Bradsaúde Document: Q2 2026 - Filings
- 4 months ago - Bradsaúde Earnings Call Transcript: Q1 2026 - Transcripts
- 4 months ago - Bradsaúde Earnings release: Q1 2026 - Filings
- 4 months ago - Bradsaúde Slides: Q1 2026 - Filings